INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 1,100 | $20.34 | 106,251 |
| Aug 20, 2020 |
Director
Trans History: 326
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 3,454 | $617.64 | 106,436 |
| Jan 19, 2012 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 13,193 | $79.53 | 106,544 |
| May 20, 2013 |
SVP Finance and Admin CFO and
Trans History: 645
|
SVP Finance and Admin CFO and | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 7,852 | $266.64 | 106,727 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $20.30 | 107,351 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 500 | $20.28 | 107,551 |
| Nov 22, 2019 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 46,138 | -- | 107,655 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 3,200 | $20.27 | 108,051 |
| May 01, 2013 |
Director, President & CEO
Trans History: 427
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 400 | $235.75 | 108,315 |
| Dec 16, 2014 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 108,380 | -- | 108,380 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.